REGN |
REGENERON PHARMACEUTICALS, INC. |
Feb 2, 2024 |
3 |
-117,227 |
4 |
Feb 6, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 31, 2024 |
3 |
-117,272 |
4 |
Feb 2, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 23, 2024 |
6 |
-464,512 |
4 |
Jan 25, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 17, 2024 |
3 |
-140,558 |
4 |
Jan 18, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 12, 2024 |
3 |
-224,022 |
4 |
Jan 17, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 4, 2024 |
3 |
-124,141 |
4 |
Jan 8, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 2, 2024 |
6 |
-338,439 |
4 |
Jan 4, 2024 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 27, 2023 |
6 |
-407,916 |
4 |
Dec 29, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 12, 2023 |
4 |
-5,717,506 |
4 |
Dec 14, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 8, 2023 |
3 |
-3,573,573 |
4 |
Dec 12, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 23, 2023 |
1 |
-188,212 |
4 |
Aug 25, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Mar 27, 2023 |
22 |
-1,841,829 |
4 |
Mar 29, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Feb 3, 2023 |
18 |
-1,753,048 |
4 |
Feb 7, 2023 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 16, 2022 |
2 |
0 |
4 |
Dec 20, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 8, 2022 |
4 |
-962,523 |
4 |
Dec 12, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 1, 2022 |
6 |
-943,825 |
4 |
Dec 2, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Oct 31, 2022 |
13 |
-741,929 |
4 |
Nov 2, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Oct 14, 2022 |
4 |
-541,258 |
4 |
Oct 18, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Apr 7, 2022 |
28 |
-3,276,534 |
4 |
Apr 11, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Mar 31, 2022 |
5 |
-450,357 |
4 |
Apr 1, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Mar 28, 2022 |
29 |
-3,758,253 |
4 |
Mar 30, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Mar 21, 2022 |
4 |
-270,821 |
4 |
Mar 23, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Mar 16, 2022 |
5 |
-315,832 |
4 |
Mar 18, 2022 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 10, 2021 |
5 |
-625,837 |
4 |
Dec 14, 2021 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 8, 2021 |
21 |
-1,101,437 |
4 |
Dec 10, 2021 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Nov 16, 2021 |
4 |
-941,470 |
4 |
Nov 18, 2021 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 31, 2021 |
3 |
-63,333 |
4 |
Sep 1, 2021 |
EVP Finance CFO |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 6, 2021 |
22 |
-1,159,116 |
4 |
Aug 10, 2021 |
EVP Finance CFO |